Bergamini Barbara Maria, Losi Monica, Vaienti Francesca, D'Amico Roberto, Meccugni Barbara, Meacci Marisa, De Giovanni Donatella, Rumpianesi Fabio, Fabbri Leonardo M, Balli Fiorella, Richeldi Luca
University of Modena and Reggio Emilia, Department of Respiratory Diseases, Policlinico Hospital of Modena, Via del Pozzo 71, 41100 Modena, Italy.
Pediatrics. 2009 Mar;123(3):e419-24. doi: 10.1542/peds.2008-1722.
The accurate diagnosis of latent tuberculosis infection reduces the risk of progression to severe disseminated disease. However, in young children, a major limitation of the standard tuberculin skin test is that false-negative results cannot be detected. The new interferon-gamma release assays QuantiFERON-TB Gold (Cellestis Carnegie Victoria, Australia), QuantiFERON-TB In-Tube (Cellestis), and T-SPOT.TB (Oxford Immunotec, Abingdon, United Kingdom) show promise of greater accuracy, but they may also be affected by impaired cellular immunity, resulting in indeterminate results (ie, insufficient response in positive-control wells).
To evaluate the impact of age on the performance of interferon-gamma release assays when used in a routine hospital setting among children tested for suspected active or latent TB infection.
We retrospectively studied 496 children 0 to 19 years of age who had been tested with the tuberculin skin test and at least 1 interferon-gamma release assay: 181 with QuantiFERON-TB Gold and 315 with QuantiFERON-TB In-Tube. In 154 of the children, paired interferon-gamma release assay testing was available: 87 with QuantiFERON-TB Gold/T-SPOT.TB and 67 with QuantiFERON-TB In-Tube/T-SPOT.TB.
Compared with T-SPOT.TB, the rates of indeterminate results were significantly higher for both QuantiFERON-TB Gold and QuantiFERON-TB In-Tube. QuantiFERON-TB Gold and QuantiFERON-TB In-Tube also gave indeterminate results more frequently in children <4 years of age than in those >/=4 years of age. Indeterminate results were associated with younger age for both QuantiFERON-TB Gold and QuantiFERON-TB In-Tube but not for T-SPOT.TB. Considering age as a binary variable (<4 and >/=4 years of age), a significantly higher concentration of phytohaemagglutinin-produced interferon-gamma was observed in older children with both QuantiFERON-TB Gold and QuantiFERON-TB In-Tube.
Different blood tests for the diagnosis of latent tuberculosis infection in children seem to perform differently, because both QuantiFERON-TB tests were more likely than T-SPOT.TB to give indeterminate results in children <4 years of age.
潜伏性结核感染的准确诊断可降低进展为严重播散性疾病的风险。然而,对于幼儿而言,标准结核菌素皮肤试验的一个主要局限性在于无法检测出假阴性结果。新型的γ-干扰素释放检测方法,如QuantiFERON-TB Gold(澳大利亚卡内基维多利亚州Cellestis公司)、QuantiFERON-TB In-Tube(Cellestis公司)和T-SPOT.TB(英国阿宾顿牛津免疫技术公司),显示出更高准确性的前景,但它们也可能受到细胞免疫受损的影响,导致结果不确定(即阳性对照孔反应不足)。
评估年龄对γ-干扰素释放检测方法在常规医院环境中用于疑似活动性或潜伏性结核感染检测的儿童时的性能的影响。
我们回顾性研究了496名0至19岁的儿童,这些儿童接受了结核菌素皮肤试验以及至少一种γ-干扰素释放检测:181名接受了QuantiFERON-TB Gold检测,315名接受了QuantiFERON-TB In-Tube检测。在154名儿童中,可获得配对的γ-干扰素释放检测结果:87名接受了QuantiFERON-TB Gold/T-SPOT.TB检测,67名接受了QuantiFERON-TB In-Tube/T-SPOT.TB检测。
与T-SPOT.TB相比,QuantiFERON-TB Gold和QuantiFERON-TB In-Tube的不确定结果发生率均显著更高。QuantiFERON-TB Gold和QuantiFERON-TB In-Tube在4岁以下儿童中出现不确定结果的频率也高于4岁及以上儿童。对于QuantiFERON-TB Gold和QuantiFERON-TB In-Tube而言,不确定结果均与年龄较小相关,但T-SPOT.TB并非如此。将年龄视为二元变量(<4岁和≥4岁),在接受QuantiFERON-TB Gold和QuantiFERON-TB In-Tube检测的年龄较大儿童中,观察到植物血凝素诱导产生的γ-干扰素浓度显著更高。
用于诊断儿童潜伏性结核感染的不同血液检测方法表现似乎不同,因为在4岁以下儿童中,两种QuantiFERON-TB检测方法比T-SPOT.TB更易出现不确定结果。